Biopharmaceuticals Company
Ongoing Engagement Capital Markets Advisor September 2021
The Brookline Brief
Our Monthly Insight into U.S. Healthcare Equity Markets Undeterred by a host of potential macroeconomic headwinds – ranging from a near-term “tapering” by the Federal Reserve of its ongoing bond-buying programs to the frustrating and increasingly disruptive resilience of the novel SARS nCoV-2 coronavirus in the US and around the globe – US equities nevertheless…
